Viveka Roychowdhury

1 week ago | expresspharma.in | Viveka Roychowdhury

Share With close to three decades of experience in setting up logistics parks at ports, across MENA and India, you have seen the evolution of pharma logistics. What are the key drivers for the current transformation of the pharma and medical device logistics sector in India? And where do free trade warehousing zones (FTWZs) fit into these business imperatives?

1 week ago | expresspharma.in | Viveka Roychowdhury

Share  Give a short background of the founders IntegriMedical is led by a team of experienced professionals with a strong background in medical technology, business development and healthcare innovation. The key leadership team includes myself, Ankur Naik, MD, Scott McFarland, CEO and Mark Timm, COO.

2 weeks ago | expresshealthcare.in | Viveka Roychowdhury

In fact, tariffs on medical device imports could achieve exactly the opposite effect of their initial intent. As Choudary points out, “Economies prosper when they focus on their strengths, leveraging comparative advantages to enhance global trade. However, by disrupting supply chains through excessive tariffs, the US risks not only reducing efficiency but also increasing healthcare costs for its own citizens.

2 weeks ago | expresspharma.in | Viveka Roychowdhury

Share On April 2, US President Trump is expected to follow through on his threats to impose 25 per cent tariffs on drug imports from India. And even if the tariff announcements are deferred or lower than expected, the US Trade Representative (US TR)’s latest report gives some clues that the re-calibration indicated by President Trump will continue.

1 month ago | expresspharma.in | Viveka Roychowdhury

Share What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.